Clinical trials
Neurology clinical trials
Below are recruiting neurology clinical trials, each written for real people, not researchers. We’re tracking 379 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT03322306Enrolling by invitation
Genetic testing study for inherited neurological conditions
This trial looks for genetic causes of inherited (in family) neurological diseases by using genetic screening. If you might have an inherited neurological condition, this study may help explain why symptoms happen and guide future care.
Hong Kong, ShatinAges 18–80 - NCT02382601Recruiting
Study of pregnancies with slow fetal growth
This study follows pregnancies where the baby appears smaller than expected on ultrasound. It may help researchers better understand why this happens and how to monitor care over time.
Aurora, ColoradoAges 18–45 - NCT02544100Recruiting
Study for newborns with brain or nervous system problems
This study enrolls newborns (within the first 28 days of life) who have specific brain or nervous system conditions. It tests how these conditions are tracked and studied, which may help improve care and understanding over time.
Shanghai, Shanghai MunicipalityAges Up to 4 weeks - NCT05740683Recruiting
Studies alpha-synuclein and brain symptoms in smell loss
This study looks at whether a specific brain protein (alpha-synuclein) is linked to other neurologic symptoms in people who have long-lasting smell loss. It may help researchers understand what causes smell loss and how it relates to later brain or nerve changes.
CopenhagenAges 55–75 - NCT04866251Recruiting
Tests gag reflex differences in healthy people and patient groups
This study measures your gag reflex (how strongly you gag when stimulated) and compares it across different groups. The results may help improve screening for swallowing problems (called dysphagia).
Giessen, HesseAges 18 years+ - NCT07393620Recruiting
Predicting brain outcomes in newborns with mild oxygen loss
This study uses brain monitoring and oxygen measurements in newborns who had a mild lack of oxygen at birth to see if these tests can predict how the baby will develop. The goal is to find early signs that might help guide care.
BursaAges birth–6 hours - NCT07369999RecruitingPhase 3
Butylphthalide plus tenecteplase for mild disabling stroke
This trial tests whether adding butylphthalide (a drug that improves blood flow) to the standard clot-busting medicine tenecteplase can help people with mild but disabling strokes recover better. If you have had a mild stroke within the last 4.5 hours and are 18–80, this study might be an option for you.
Changsha, HunanAges 18–80 - NCT05881226Recruiting
Study using biomarkers to learn about neurological diseases
This study looks at “biomarkers,” which are measurable signs in the body, to learn more about neurological diseases. If you join and can be followed over time, your information may help researchers understand disease patterns and improve care.
Changchun, JilinAges Any age - NCT05375812Recruiting
Deep health study of Gulf War veteran symptoms and brain-body changes
This study closely measures health, thinking, and body function in Gulf War veterans using detailed testing (including exercise testing and possibly brain scans). It aims to better understand what may be driving Gulf War illness and related symptoms, which could improve future care.
Bethesda, MarylandAges 48–70 - NCT04799288RecruitingPhase 1/Phase 2
Teriflunomide for HTLV-1 spinal cord stiffness and weakness
This early-phase trial tests whether teriflunomide can help people with HTLV-1 associated myelopathy (HAM) or tropical spastic paraparesis (TSP). It also checks safety and how well the treatment can be followed over time.
Bethesda, MarylandAges 18–120 - NCT06958523Recruiting
Apple Health Study for US iPhone users
This study uses your iPhone and optional devices like Apple Watch to collect health data over time. It aims to discover how technology can help monitor and improve health.
Washington D.C., District of ColumbiaAges 18 years+ - NCT07124377Recruiting
Study of hereditary ATTR amyloidosis symptoms
This study looks at how a specific genetic change (Val50Met) affects people with hereditary ATTR amyloidosis. It may help doctors better understand the condition and its symptoms.
Charata, Chaco ProvinceAges 20 years+ - NCT07254663Recruiting
Gel and medication swallowing study for dysphagia
This study tests how well people with swallowing problems (dysphagia) can swallow gels and medications. It may help find better ways to take medicine safely.
Düsseldorf, North Rhine-WestphaliaAges 18 years+ - NCT05924087Recruiting
Treatment study for narrowing of the windpipe after tracheotomy
This trial tests an interventional treatment for narrowing of the windpipe (tracheal stenosis) that happened after a percutaneous (through-skin) tracheotomy. It may help improve breathing and reduce problems caused by the narrowing.
NiddaAges 18 years+ - NCT06592196Recruiting
Statin liver safety in neurology patients
This study is looking at the safety of statin medications (cholesterol-lowering drugs) on the liver in people hospitalized for neurological conditions like stroke, headache, or dizziness. The goal is to see if these drugs are safe for this group of patients.
Shanghai, Shanghai MunicipalityAges 18–85 - NCT05306327Recruiting
Study nerves and breathing after stopping life support
This trial looks at how a person’s nervous system signals change right after life support is withdrawn. It may help doctors better understand what to expect during end-of-life care and how to monitor the process.
Calgary, AlbertaAges 18 years+ - NCT07287891Recruiting
Predicting brain causes of dizziness in the ER
This study is observing patients who come to the emergency department with vertigo, dizziness, or unsteadiness. Researchers want to predict which of these symptoms are caused by a brain problem (central nervous system), helping doctors make fast and accurate decisions.
Pavia, PaviaAges 18 years+ - NCT06791044Recruiting
Vitamin D and bone health in neurological patients
This trial looks at how vitamin D levels relate to bone strength and daily function in people with neurological disorders. If you have a neurological condition or are healthy, you may join to help understand how vitamin D affects bone health.
Nea Liosia, AthensAges 20–85 - NCT07207122Recruiting
Focused ultrasound for Parkinson's cognitive symptoms
This trial tests whether a non-invasive ultrasound treatment, called transcranial focused ultrasound stimulation (tFUS), can improve movement and thinking in people with Parkinson's disease. It may be an option for those whose symptoms are not well controlled by medication alone.
Tucson, ArizonaAges 22–80 - NCT07257302Recruiting
Breathing muscle training for ALS patients
This study tests whether a special breathing exercise called Lung Insufflation Capacity (LIC) training can help people with ALS maintain or improve their breathing muscle strength. Participants must be age 20 or older, have a confirmed ALS diagnosis, and not be using a breathing machine at the start of the training.
Kodaira, TokyoAges 20 years+ - NCT05514106Enrolling by invitationPhase 4
MIBG heart scan study for aging and neurologic conditions
This Phase 4 study tests how an iodine-based heart scan (a special imaging test) works in people with certain neurologic diagnoses and aging-related conditions. It may help researchers better understand the heart-brain connection in these disorders and improve future care.
Rochester, MinnesotaAges 40–90 - NCT07416188RecruitingPhase 1/Phase 2
LMP744 drug for returning glioblastoma
This trial tests an experimental drug called LMP744 for people whose glioblastoma has come back. It aims to see if the drug can slow or stop tumor growth by targeting specific proteins in cancer cells.
Bethesda, MarylandAges 18–99 - NCT07731334Recruiting
Memory problems in non-neurology rehab patients
This study looks at how common mild cognitive impairment and dementia are in people staying in rehabilitation units for heart, lung, or orthopedic problems. It aims to understand memory and thinking issues that may be overlooked in these settings.
Florence, FIAges 45 years+ - NCT07258290Recruiting
Freesolve Magnesium Scaffold for Heart Artery Blockages
This trial tests a new dissolvable magnesium scaffold to treat blockages in heart arteries. It is designed for people with stable heart pain or certain recent heart attacks, and it aims to open blocked arteries and then slowly dissolve over time.
Washington D.C., District of ColumbiaAges 18–80
Hear when a new Neurology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for neurology?
- Yes. Clin2 currently lists 379 recruiting neurology studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a neurology trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a neurology trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.